Company intelligence / Profile preview

ZetrOZ Systems

Trumbull, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

ZetrOZ Systems’ sustained acoustic medicine (sam®) wearable ultrasound devices are FDA-cleared, with clinical evidence showing 50–70% pain reduction in one week for patients with musculoskeletal conditions. They have been validated in more than 42 peer-reviewed publications and 20 clinical studies, and are widely used in athletes, veterans, and the general population, showing significant improvement in pain and healing outcomes.

Therapeutic areas: OtherNeurologyRheumatology
Modalities: DeviceNon-pharmacological therapyBioelectronic deviceUltrasound-based therapy
Industry: Therapeutic Medical Devices

Partnerships

Orthopedic FoundationNational Institute on Aging (NIH)U.S. Department of Veterans AffairsU.S. military medical centers

Beyond the preview

Go deeper on ZetrOZ Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZetrOZ Systems.

Explore the full profile